Association Between CRSA and OSA

Obstructive Sleep Apnea Clinical Trial

— CRSA  

Official title:

The Association Between Central Serous Chorioretinopathy and the Obstructive Sleep Apnea

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04634786
• Other study ID #: 2020-A02305-34
• Status: Recruiting
• Start date: February 6, 2021
• Est. completion date: August 6, 2021

Study information

• Verified date: April 2021
• Source: Poitiers University Hospital
• Contact: Nicolas LEVEZIEL, Pr
• Phone: 0549444182
• Email: nicolas.leveziel[@]chu-poitiers.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This goal of this study is to know the association between the central serous chorioretinopathy and the obstructive sleep apnea. Many studies have been done in order to assess the association between the central serous chorioretinopathy and obstructive sleep apnea and the results are always controverses actually.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 70
• Est. completion date: August 6, 2021
• Est. primary completion date: August 6, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Central serous chorioretinopathy since 6 months at least
• Patients beyond 18 years old

Exclusion Criteria:

• All retina pathology will be excluded : diabetes with affected retina, maculopathy, retina central veinous oclusion, epithéliopathy

Related Conditions & MeSH terms

• Chorioretinopathy
• Obstructive Sleep Apnea
• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive

Locations

Country	Name	City	State
France	CHU de Poitiers	Poitiers

Sponsors (1)

Lead Sponsor	Collaborator
Poitiers University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Association between central serous chorioretinopathy and the obstructive sleep apnea.	Percentage of high risks of obstructive sleep apnea in patients affected by central serous chorioretinopathy in using the Berlin survey.; The Berlin questions include 3 categories: The category 1 is positive if 2 answers are positive. The category 2 is positive if 2 answers are positive. The category 3 is positive if 1 answer is positive. Finally, if 2 categories are positive, the patient is considered as high risk of obstructive sleep apnea.	During 3 months we will collect the results of Berlin survey.